Title:
APPLICATION OF JAK INHIBITOR IN KIDNEY DISEASE
Document Type and Number:
WIPO Patent Application WO/2022/122010
Kind Code:
A1
Abstract:
Provided is an application of a JAK inhibitor in kidney disease. Specifically, provided is a use of a JAK inhibitor in the preparation of a drug for treating or preventing kidney disease.
More Like This:
Inventors:
LIAO CHENG (CN)
SU LU (CN)
LIN KAN (CN)
ZHANG JINGYANG (CN)
SU LU (CN)
LIN KAN (CN)
ZHANG JINGYANG (CN)
Application Number:
PCT/CN2021/137040
Publication Date:
June 16, 2022
Filing Date:
December 10, 2021
Export Citation:
Assignee:
JIANGSU HENGRUI MEDICINE CO (CN)
International Classes:
A61K31/519; A61P13/12
Domestic Patent References:
WO2020169783A1 | 2020-08-27 | |||
WO2013091539A1 | 2013-06-27 |
Foreign References:
CN101965184A | 2011-02-02 | |||
CN110177549A | 2019-08-27 | |||
CN108026582A | 2018-05-11 | |||
CN110913900A | 2020-03-24 | |||
CN202011458342A | 2020-12-11 |
Other References:
CAO, YU: "Role of JAK/STAT Signaling Pathway in the Progress of Kidney Disease", CHINESE JOURNAL OF CLINICIANS, CN, vol. 11, no. 1, 1 January 2017 (2017-01-01), CN , pages 114 - 118, XP055942266, ISSN: 1674-0785, DOI: 10.3877/cma.j.issn.1674-0785.2017.01.024
NAT REV NEPHROL., vol. 13, no. 4, 2017, pages 241 - 257
CURR OPIN NEPHROL HYPERTENS., vol. 24, no. 1, 2015, pages 88 - 95
AM J KIDNEY DIS. JUL, vol. 72, no. 1, pages 136 - 148
NAT REV NEPHROL., vol. 13, no. 4, 2017, pages 241 - 257
CURR OPIN NEPHROL HYPERTENS., vol. 24, no. 1, 2015, pages 88 - 95
AM J KIDNEY DIS. JUL, vol. 72, no. 1, pages 136 - 148
Attorney, Agent or Firm:
SHANGHAI BESHINING LAW OFFICE (CN)
Download PDF: